Authors:
OLIVEIRA PM
SILVA AE
KEMP VL
BARBOZA DV
FERRAZ ML
Citation: Pm. Oliveira et al., FOLLOW-UP OF 3 SCHEDULES OF VACCINATION AGAINST HEPATITIS-B IN HEALTH-CARE WORKERS, Hepatology, 26(4), 1997, pp. 1790-1790
Authors:
NETO MC
DRAIBE SA
SILVA AEB
FERRAZ ML
GRANATO C
PEREIRA CAP
SESSO RC
GASPAR AMC
AJZEN H
Citation: Mc. Neto et al., INCIDENCE OF AND RISK-FACTORS FOR HEPATITIS-B VIRUS AND HEPATITIS-C VIRUS-INFECTION AMONG HEMODIALYSIS AND CAPD PATIENTS - EVIDENCE FOR ENVIRONMENTAL TRANSMISSION, Nephrology, dialysis, transplantation, 10(2), 1995, pp. 240-246
Authors:
OLIVEIRA PMC
SILVA AE
KEMP VL
JULIANO Y
FERRAZ ML
Citation: Pmc. Oliveira et al., COMPARISON OF 3 DIFFERENT SCHEDULES OF VACCINATION AGAINST HEPATITIS-B IN HEALTH-CARE WORKERS, Vaccine, 13(9), 1995, pp. 791-794
Authors:
BRANDAOMELLO CE
ADANIA RS
PEREIRA CA
KEMP VL
FERRAZ ML
SILVA AE
Citation: Ce. Brandaomello et al., LIVER-DISEASE IN DRUG-ABUSERS - A CLINICAL, SEROLOGICAL AND HISTOPATHOLOGICAL STUDY, Hepatology, 19(4), 1994, pp. 90000044-90000044
Authors:
FIGUEIREDO VM
CASTELOFILHO A
SILVA AE
FERRAZ ML
Citation: Vm. Figueiredo et al., ECONOMIC-ANALYSIS OF SCREENING STRATEGIES FOR HEPATITIS-B VACCINATIONPROGRAM - A COST-MINIMIZATION STUDY, Hepatology, 19(4), 1994, pp. 90000061-90000061
Authors:
LOPES EPA
OLIVEIRA JM
SZEJNFELD J
BORGES ACS
FERRAZ ML
SILVA AE
Citation: Epa. Lopes et al., THE NATURE OF UNEXPLAINED PERSISTENT ALANINE AMINOTRANSFERASE ELEVATIONS IN ASYMPTOMATIC BLOOD-DONORS, Hepatology, 19(4), 1994, pp. 90000093-90000093
Authors:
LOPES EPA
FERRAZ ML
SILVA AE
SETTE H
SILVA NP
GUIMARAES RX
Citation: Epa. Lopes et al., AUTOANTIBODIES BEFORE, DURING AND AFTER INTERFERON TREATMENT IN TYPE-B AND TYPE-C CHRONIC HEPATITIS, Hepatology, 19(4), 1994, pp. 90000093-90000093
Citation: Pm. Oliveira et al., IMMUNIZATION AGAINST HEPATITIS-B - COMPARISON BETWEEN PLASMA-DERIVED AND YEAST-DERIVED VACCINES, Hepatology, 19(4), 1994, pp. 90000112-90000112
Authors:
LOPES EPA
OLIVEIRA PM
SILVA AE
FERRAZ ML
COSTA CHRM
MIRANDA W
DIB SA
Citation: Epa. Lopes et al., EXACERBATION OF TYPE-2 DIABETES-MELLITUS DURING INTERFERON-ALFA THERAPY FOR CHRONIC HEPATITIS-B, Lancet, 343(8891), 1994, pp. 244-244